La Comisión Europea ha aprobado el fármaco 'JEMPERLI' (dostarlimab), de GSK ... línea para las mujeres adultas con cáncer de endometrio avanzado, tanto de nuevo diagnóstico como en recaída.

Jan. 30, 2025 — A new study shows that artificial intelligence (AI) can help doctors make better decisions when treating cancer. However, it also highlights challenges in how doctors and AI work ...

You can’t pretend the pink pachyderm isn’t staring you in the face on Saturday. But if you must draw attention to it, at least soften the hard edges of your truth with graceful diplomacy. A ...

At the time, a company executive heralded the regimen as "a new standard of care for patients with EGFR non-small cell lung cancer." Also in Europe, officials have endorsed GSK's Jemperli to treat ...

Women in England with a specific type of endometrial cancer will be able to access an immunotherapy for the first time, after NICE backed use of GlaxoSmithKline's PD-1 inhibitor Jemperli via the ...

The new approval bolsters AZ's position in what is becoming a battle with GSK and MSD in first-line endometrial cancer, with Imfinzi and Imfinzi/Lynparza pitted against the GSK's Jemperli ...

Self-sabotaging? You claim you want success but continue to shrink from the spotlight! It’s time to get comfortable with recognition. You hit a similar roadblock once and stopped when you should ...

Lung cancer is one of the most common types of cancer in the United States and a leading cause of cancer deaths. However, the timeline of how the disease progresses can vary based on several factors.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Teva Pharmaceutical Industries Ltd. ADR-0.62% $20.28B ...